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Because its malfunction leads to critical metabolic damage affecting the entire body, the liver is a principle target organ for gene therapy. The efficacy of the therapy will depend in large part on the ability to target specifically liver cells for corrective gene transfer. Receptor-mediated gene transfer is one promising approach to the problem, provided the relevant receptors are selectively expressed by hepatocytes.
Asialoglycoprotein receptors on the plasma membranes of hepatocytes have been a focus of research interest for receptor-mediated targeting since Wu and Wu first introduced DNA into hepatocarcinoma cells 1 and rat liver 2 in the form of a complex with asialoglycoprotein and polylysine. Receptor-mediated gene transfer does not pose the risk of adverse effects carried by some other methods (eg viral infection derived from viral vectors and cytotoxic effects from liposomes); thus, it would seem to be an attractive method for gene transfer in vivo. However, this approach has not yet become practical for gene therapy, because the methods developed so far do not effectively mediate DNA incorporation into target cells, and the expression of genes that are introduced is only transient. In addition, it is clear that preparation of DNA-ligand complexes remains a significant technical obstacle, and improved methods will likely be required To date, a variety of DNA-ligand complexes have been developed. [3] [4] [5] [6] [7] [8] [9] Polycations and proteins that carry numerous positive charges electrostatically bind polyanionic DNA to form condensed molecular aggregates. 10 Polylysine is the most commonly used DNA binding moiety; it has an electrostatic affinity with DNA, and the lysine ⑀-amino groups can be covalently bound to ligand molecules. On the other hand, DNA-polylysine complexes formed in physiological saline tend to aggregate or precipitate due to neutralization of the charges. Consequently, it is difficult to sustain concentrations of soluble DNA-ligand complex that are high enough to mediate in vivo gene transfer. Perales et al 11 analyzed the physical and chemical nature of various complexes formed through a series of processes. They were then able to prepare small (12 nm in diameter) molecular aggregates of DNA-galactosyl-polylysine complex which proved useful for gene transfer both in vitro and in vivo. Even these tiny molecular aggregates tended to precipitate at physiological ionic strength, however. Thus, establishing conditions that will support high concentrations of DNAligand complex for in vivo application is an immediate research concern and a step toward the ultimate goal of developing clinically practical gene therapies.
The aim of the present study was to develop a convenient method for preparing soluble DNA-ligand complexes useful for in vivo gene transfer. To that end, we adopted a novel synthetic polypeptide that possesses affinity for DNA and binds to specific receptors in liver. This polypeptide (PLSP) is a cationic d-lysine/d-serine copolymer modified with a polyethylene glycol 5000 (PEG) at the carboxyl-terminus. In addition, the lysine ⑀-amino groups were covalently bound to galactose (galactosyl-PLSP), an asialoglycoprotein receptor ligand. The d-lysine/d-serine copolymer was synthesized by the NCA method and methoxy PEG-NH 2 5000 was used as an initiator. 12 Two kinds of PLSP with molar ratios of Lys/Ser/PEG = 33/36/1 (Mr 12 400) and 53/60/1 (Mr 17 000) were used in this study. Both functioned in the same manner. Galactosyl-PLSP was prepared as described except that 20 mm Hepes buffered saline, pH 7.3 (HBS) was used as the dialysis buffer. 13 Galactose occupied 2-4% of the amino groups in PLSP as determined by the resorcinol sulfuric acid micromethod.
14 It was anticipated that the hydrophilic nature of the copolymer would increase the effective concentration of DNA complex through an excluded volume effect: the serine moiety in PLSP contains hydrophilic OH group, while polyethylene glycol bound to the C-terminus of PLSP is amphipathic. Another advantage was that polyethylene glycol may prevent phagocytosis of the DNA-ligand complexes by macrophages.
We initially determined whether galactosyl-PLSP was able to form a complex with plasmid DNA. Complex formation was confirmed by the retarded electrophoretic migration of plasmid DNA on agarose gels ( Figure 1) ; migration of DNA/galactosyl-polylysine was used for comparison. The distance migrated by the DNA band decreased as the concentration of galactosyl-PLSP increased until the DNA:galactosyl-PLSP mixing ratio reached 1:1.2 (w/w), at which point DNA no longer migrated out of the sample wells. It was noted that the band representing free DNA was not detected when mixing ratios were larger than 1:1.2. For subsequent experiments, we used the DNA/galactosyl-PLSP complex formed when the DNA:galactosyl-PLSP ratio was 1:3; this ratio gave rise to the maximal rate of reporter gene expression.
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Figure 4 Fluorescence signals from enhanced green fluorescence protein (EGFP) expressed in mouse liver. Five-week-old female ddy mice were injected via the tail vein with either 75 g of pCAGEGFP, a plasmid encoding the EGFP gene, complexed with galactosyl-PLSP, or they were injected with complexed pCAGLUC as described in Figure 3. Two days after injection, the livers were harvested and fixed in 4% paraformaldehyde overnight. The tissues were then cut into 50 m thick sections, mounted on glass slides, examined under an Olympus BH2-RFCQ fluorescence microscope (Olympus, Tokyo, Japan) equipped with a BP 490-F 455 filter set, and photographed. (a-d) pCAGEGFP was introduced. (e and f) pCAGLUC was introduced as a control. (a, c and e) Light microscopic images. (b, d, and f) Fluorescence microscopic images. (a, b, e and f) Original magnification ×40. (c and d)
Original magnification ×100.
Two types of DNA-ligand complexes were generated using either galactosyl-polylysine or galactosyl-PLSP at a DNA concentration of 50 g/ml in HBS. The complex was prepared by the dropwise addition of a solution of 50 g of plasmid in 700 l of HBS to a solution of 150 g of galactosyl-PLSP or -polylysine in 300 l of HBS. The mixture was allowed to stand for 30 min at room temperature. Differences between the reaction products were obvious (Figure 2) . Solution containing the DNA/galactosyl-polylysine complex appeared dense and opaque, indicating the presence of a relatively coarse precipitate. In contrast, the DNA/galactosyl-PLSP solution was clear which is consistent with generation of a fine precipitate and likely results from the hydrophilicity of PLSP. The average particle size of DNA/galactosyl-PLSP complex measured by Malvern Analysis (AutoSizer 4700) (Malvern, Worcestershire, UK) was 207.5 ± 124.2 nm in diameter. Aggregation made it impossible to determine the particle size of the DNA/galactosyl-polylysine complex.
We next examined in vivo expression of reporter genes introduced into mice in the form of plasmid DNA/galactosyl-PLSP complexes. The complexes were prepared at a DNA concentration of 50 g/ml in HBS as mentioned above. This was accomplished using pCAG-LUC, a plasmid encoding the firefly luciferase gene, and pCAGEGFP, encoding the enhanced green fluorescent protein (EGFP) gene; in each case CAG served as the promoter. 15 Within 2 days of injecting 1.5 ml of HBS containing 75 g pCAGLUC complexed with galactosyl-PLSP into their tail veins, elevated levels of luciferase activity were observed in the livers of injected mice. In contrast, luciferase activity in kidney, spleen, lung and heart was negligible (Figure 3 ). High levels of hepatic luciferase activity were sustained for a minimum of 7 days following introduction of the gene. Thereafter, activity gradually declined, but luciferase activity was still detectable at the end of 4 weeks (data not shown). In similar fashion, fluorescent EGFP was found to be expressed throughout the livers of pCAGEGFP-injected mice ( Figure 4) .
We also determined the most effective promoters for driving genes in mouse liver. The respective luciferase gene expression driven by each of four promoters (SV40, CMV, albumin and CAG) was assessed following introduction of the plasmid DNA/galactosyl-PLSP complex into mouse liver ( Figure 5 ). The CAG promoter, which produces high levels of expression of ligated genes in various cell lines and in the tissues of transgenic mice, 15 was the strongest among the four promoters examined. The tissue-specific albumin promoter and enhancer 16 was also found to be effective in mouse liver.
With respect to adverse effects, galactosyl-PLSP admin- istered as a component of the DNA-ligand complex at a dose of 225 g per mouse (9 mg/kg body weight) produced no detectable toxicity. Administration of 200 mg/kg body weight of PLSP alone proved lethal within 30 min (data not shown). In addition, vector molecules that are foreign to a host are usually immunogenic, and this was a source of concern with respect to PLSP. To decrease its immunogenicity, we used a d-type copolymer instead of the natural l-type polymer. Indeed, preliminary tests showed that injection of an l-lysine/lserine copolymer invoked immune responses, whereas the d-type copolymer induced little immunogenicity in the tested animals (data not shown). Wu and Wu 1 first reported asialoglycoprotein receptormediated introduction of a gene specifically targeted to hepatocytes. Although this technique has been applied to cultured cells as well as whole animals in many laboratories, only a few describe successful expression of the introduced gene, especially in whole animals. 17, 18 In order to maintain prolonged expression of the transferred gene, Wu and colleagues performed partial hepatectomy before or after introducing genes into liver cells. [19] [20] [21] In other studies, animals were pretreated with colchicine and chloroquine to obtain high expression levels of transgene. 6 In contrast, we observed efficient expression of reporter genes in mouse liver without prior surgical procedures or drug treatment.
These experiments demonstrate that synthetic PLSP is an effective reagent facilitating formation of DNA-ligand complexes for subsequent receptor-mediated gene transfer. PLSP thus appears to be a promising tool enabling targeted transfer of genes in vivo. Its use has the potential to bring us closer to the goal of clinically practical gene therapy, although further improvements in the preparation of DNA-ligand complexes as well as reduction of their immunogenicity and toxicity remain subjects for future study.
